Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PODD · against 160 other Healthcare companies of similar size
Ranked #64 of 161 · scores higher than 59% of peers
Bars: peers in each 10-point band of the valuation score24 peers with a valuation score of 60–69, including PODD · Click a bar to see the companies
Mainly thanks to its earnings yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | PODD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 160 reported | 3.4% | 2.6% | 64% | 30% | |
| EBITDA yieldHigher is better · 160 reported | 5.4% | 4.7% | 57% | 50% | |
| Free cash flow yieldHigher is better · 95 reported | 2.5% | 2.3% | 51% | 20% | |
| Book yieldHigher is better · 159 reported | 13.2% | 18.6% | 33% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 4 | 21.5B USD | 95 | 60 | |
| 62 | 626.0B INR (≈$7.5B) | 61 | 68 | |
| 62 | 10.6B USD | 61 | 64 | |
| 64 | 21.4B USD | 60 | 67 | |
| 64 | 77.1B DKK (≈$11.6B) | 60 | 47 | |
| 64 | 10.7B USD | 60 | 65 | |
| 67 | 16.7B CHF (≈$19.2B) | 59 | 47 | |
| 68 | 73.2B SAR (≈$19.8B) | 58 | 56 | |
| 68 | 7.4B USD | 58 | 67 | |
| 68 | 12.6B USD | 58 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score